(NaturalNews) A further attempt at suppressing the Vitamin D levels of the UK population was recently instigated by one of the country's largest cancer charities. The results of a recent Cancer Research epidemiological study, which looked into the rate of specific skin cancer in men, were pounced upon by the organisation who made further blanket recommendations to avoid the sun, contrary to all independent evidence.
The study showed remarkable increases in the rate of malignant melanoma, the most dangerous form of skin cancer, among men. In men over the age of 65, the rate of death from this problem has risen in the last 30 years from 4.5 per 100,000 to 15.2 per 100,000, more than a threefold increase. This increase in cancer mirrors the increase in sunscreen use and avoiding sun exposure, both of which reduce the vitamin D3 levels in the body. Vitamin D3 has been repeatedly shown to be a powerful inhibitor of cancerous development, capable of preventing 80 per cent of cancers.
Preventing cancer could prove very costly for some charities, who depend on a sympathetic public sentiment and a profitable cancer industry for survival. Cancer Research, which achieved an income of 498 million pounds (around $700m) last year and has been criticised for providing their executives with limousines, appeared keen to use the study to encourage further vitamin D deficiency. Caroline Cerny, Cancer Research's SunSmart manager, said: "These figures show that a worryingly high number of men are dying unnecessarily from malignant melanoma because of the rapidly rising numbers diagnosed with the disease."
However, what Cancer Research seemed keen to avoid talking about was that the rise in malignant melanoma had occurred at a time that use of sunscreen had also soared. The UK's Office for National Statistics showed that sunscreen use (relative to
sun exposure) among men had increased to 37 percent by 1998, a marked improvement on previous years. They also failed to discuss exactly why older men, the very group least likely to be regularly exposed to the sun, had suffered a disproportionately high increase in their likelihood of developing the disease. There was no recognition whatsoever of the recent study from the Environmental Working Group, which showed in no uncertain terms that more than half of commercial sunscreens actually accelerate
cancer.
In fact, spokespeople seemed far more interested in trotting out the same tired lines about using poisonous sunscreens and avoiding direct sunshine. Cerny continued: "Too often men leave it up to their partners or mothers to remind them to use sunscreen or cover up with a shirt and hat, and even to visit the doctor about a worrying mole,"
While no-one disputes that getting sunburn is harmful and should always be avoided, the hype over avoiding the sun remains both unsupported and a direct contravention of common sense. As the evidence supporting the anti-carcinogenic effects of vitamin D continues to mount on a monthly basis, starving ourselves of this protective nutrient seems to be the most efficient way of developing cancer. Maintaining a sensible level of sun exposure (as humans have done for the last 400,000 years) appears to be our best bet.
References:
http://www.google.com/hostednews/ukpress/article/ALeqM5g1l-93oxntm2jm...http://news.bbc.co.uk/1/hi/health/10172892.stmhttp://www.statistics.gov.uk/STATBASE/xsdataset.asp?vlnk=476&More=Yhttp://www.cancerresearchuk.org/aboutus/imagesanddocuments/pdfdocs/AR...http://www.aolnews.com/health/article/study-many-sunscreens-may-be-ac...http://www.naturalnews.com/003069.htmlAbout the author
Marek Doyle is a
London personal trainer, nutritionist and the pioneer of the Combined Allergy Test, with locations serving Kensington, Chelsea, West London and Basingstoke. Marek runs Blueprint Fitness, edits the
Adrenal Fatigue Focus website and has been recognised as one of the top three trainers in the country and counts world champion athletes, models and TV celebrities amongst his clientele.
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Now Available from 
